Skip to content

E-Bike Versus Classic Bike Intervention Trial

E-Bike Study - Endurance Capacity Following 1 Month Training of Classic Bike Versus Electric-assisted Bike

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02495740
Acronym
E-bike
Enrollment
33
Registered
2015-07-13
Start date
2012-05-31
Completion date
2013-04-30
Last updated
2015-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Physical Activity

Brief summary

The effects of active commuting with an e-bike, as compared with a classic bike, on cardiorespiratory fitness and vascular health are largely unknown. To assess whether active commuting with an e-bike or a classic bike increases peak oxygen consumption (VO2peak) in untrained and overweight individuals.

Detailed description

Riding an electrically assisted bicycle (e-bike) is thought to be suitable to increase physical activity in daily life, to promote health, and to increase cardiorespiratory fitness in normal-weight individuals. The positive effect of commuting to work by a normal bike on cardiorespiratory fitness has been shown to be an important predictor of cardiovascular mortality in previous studies. We thought to improve maximal oxygen uptake by commuting to work by e-bike vs. classic bike. Besides cardiorespiratory fitness we assessed arterial stiffness as brachial-ankle pulse wave velocity as an independent predictor of cardiovascular events and all-cause mortality.

Interventions

BEHAVIORALCommuting to work

Commuting by an electric assisted bike to work for a period of 4 weeks at least 3 times per week

Sponsors

University of Basel
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

body mass index 25-35 kg/m2, and willingness to commute to work by e-bike or by normal bike at least 3 times per week with a one-way distance of ≥ 6 km.

Exclusion criteria

cycling as a leisure-time activity, active commuting to work or exercise training more than once per week within 4 weeks before the start of the study, uncontrolled cardiovascular diseases limiting cardiorespiratory fitness, stage II arterial hypertension (systolic blood pressure \> 160 mmHg, diastolic blood pressure \> 95 mmHg), renal diseases, uncontrolled diabetes mellitus (HbA1c \> 6.5%), or active malignancy or chemotherapy during the past 6 months.

Design outcomes

Primary

MeasureTime frameDescription
maximal oxygen uptake4 weeksmaximal oxygen uptake measured on a cycle ergometer with a ramp protocol

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026